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The mitochondrial protein synthesis translocase 
elongation factor G,, (EF-G,t) from bovine liver has 
been purified to greater than 90% homogeneity by a 
combination of conventional gravity and high perform- 
ance liquid chromatography. The purification scheme 
results in an approximate overall 14,000-fold purifi- 
cation with 2% total recovery of EF-G,t activity. Gel 
filtration chromatography and sodium dodecyl sulfate- 
polyacrylamide gel electrophoresis indicate that the 
mitochondrial factor is a single polypeptide with a 
molecular weight of 80,000. EF-G,t displays similar 
levels of activity on its homologous mitochondrial ri- 
bosomes and on Escherichia coli ribosomes. The mito- 
chondrial translocase is sensitive to temperatures 
above 37 “C, but the factor is partially protected from 
heat inactivation in the presence of GTP or GDP. The 
activity of EF-G,r is inhibited by treatment of the 
factor with N-ethylmaleimide. In contrast to all other 
translocases tested to date, EF-Gmt is completely re- 
sistant to the inhibiting effect of fusidic acid when 
tested on its homologous ribosomes. It displays weak 
sensitivity to this antibiotic when assayed in the pres- 
ence of heterologous E. coli ribosomes. 
Mammalian mitochondria contain a protein synthesizing 
system distinct from that of the cell cytoplasm. The transla- 
tional machinery of mammalian mitochondria remains to be 
fully explored, but recent progress indicates that this system 
has some characteristics which distinguish it from other pro- 
tein synthesizing systems. For instance, animal mitochondrial 
ribosomes have a low ribosomal RNA to protein ratio resulting 
in a sedimentation value of about 55 S compared with the 
values of 80 S for cytoplasmic and 70 S for prokaryotic 
ribosomes (1). Bovine liver mitochondrial ribosomes can se- 
lectively interact with bacterial EF’-Tu, but not with the 
corresponding cytoplasmic factor EF-1 in aminoacyl-tRNA 
binding to the A site (2). Recently, an EF-Tu.EF-Ts complex 
has been purified from bovine liver mitochondria. This com- 
plex is active on Escherichia coli ribosomes; however, unlike 
the corresponding prokaryotic and eukaryotic complexes, mi- 
tochondrial EF-Tu. EF-Ts cannot be dissociated by guanine 
nucleotides (3). Animal mitochondrial ribosomes function 
with prokaryotic EF-Tu, but they display no activity with 
either the prokaryotic or the eukaryotic translocases. 
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To date, no mammalian mitochondrial translocase has been 
purified or characterized. However, several other organellar 
translocases have been identified including those from the 
mitochondria of E. gracilis and yeast and also from the chlo- 
roplasts of E. gracilis and spinach. The molecular weights of 
these factors tend to range between 75,000 and 85,000 (a-7), 
similar to the 80,000 M, observed for E. coli EF-G (8) but 
smaller than the lOO,OOO-110,000 M, observed for cytoplasmic 
EF-2 (9). These organellar translocases are generally active 
on E. coli ribosomes but not on cytoplasmic ribosomes. Thus, 
chloroplast and mitochondrial factors tend to exhibit prop- 
erties similar to those of E. coli EF-G. Surprisingly, these 
organellar translocases do not show a strong immunological 
cross-reaction between themselves or with E. coli EF-G (6). 
This observation indicates that there are differences in the 
physical structures of these factors. Previous studies (2) have 
shown that none of these translocases is active on animal 
mitochondrial ribosomes, suggesting that the translocase rec- 
ognition and/or catalytic sites on mammalian mitochondrial 
ribosomes differ from those of other systems. We report here 
the purification and initial characterization of the bovine liver 
mitochondrial translocase (EF-G,J. 
EXPERIMENTAL PROCEDURES 
Materials 
GTP, GDP, Sephacryl S-200, and poly(U) were obtained from 
Pharmacia LKB Biotechnology Inc. DEAE-Sepharose, phos- 
pho(enol)pyruvate, glycerol, and pyruvate kinase were from Sigma. 
Nitrocellulose/cellulose acetate filter paper type HA (0.45-pm pore 
size) was from Millipore Corp. Polyethylene glycol 8000 powder was 
from Fisher Scientific. TSKgel DEAE-5PW (21.5 x 150 mm) and 
TSKgel SP-5PW (7.5 x 75 mm) columns were purchased from 
Beckman. The Progel-TSK Heparin-5PW (7.5 x 75 mm) column was 
purchased from Supelco. [14C]Phe-tRNA was prepared as described 
by Ravel and Shorey (10) using synthetases prepared by the method 
of Muench and Berg (11). Sodium fusidate was a generous gift from 
Dr. Godfredsen of Leo Pharmaceuticals (Ballerup, Denmark). Buffer 
A (20 mM Hepes-KOH, pH 7.0, 10 mM KCl, 0.1 mM EDTA, 6 mM 2- 
mercaptoethanol, 10% glycerol). 
Preparation of Bacterial Ribosomes and Elongation Factors 
E. coli ribosomes were prepared as described previously (12). Elon- 
gation factors EF-G and EF-Tu/Ts were isolated from E. coli (13) 
and further purified as described (2). 
Preparation of Bovine Liver Mitochondria and Mitochondrial 
Ribosomes 
Livers were generally obtained from male Angus cattle within 30 
min after slaughter and were immediately put on ice. All procedures 
were carried out at 4 “C, and samples were kept on ice throughout 
the preparation. About 4 kg of liver tissue were processed and ap- 
proximately 120 g of digitonin-treated mitochondrial pellets were 
obtained (3). The pellets were frozen in a dry ice/isopropyl alcohol 
bath and stored at -70 “C until ready for use. Mitochondrial ribo- 
somes were prepared as described by Matthews et al. (1) with modi- 
fications described by Eberly et al. (2). 
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Purification of Bovine Liver Mitochondrial Translocase (EF-G,I 
Crude mitochondrial extracts were prepared and subjected to chro- 
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inactivation, EF-G,, was diluted 50-fold with buffer A containing 1 
mg/ml bovine serum albumin, and 95.7 ~1 of the diluted sample was 
incubated at 44 “C for the indicated times in a final volume of 110 ~1 
containing 10 mM MgC12 and in the absence or presence of GDP (300 
FM). Similar conditions were used to determine the ability of GTP to 
protect EF-G,, from heat inactivation, except that the incubation 
mix also contained 6.5 +g of pyruvate kinase, 9 mM phosphoenolpy- 
ruvate, and either 300 pM GTP or no GTP. Approximately 1.6 ng of 
heat-treated EF-Gmt were then assayed on E. coli ribosomes for 
polymerization activity as described above. 
matography on DEAE-Sepharose as-described previously (3). The 
DEAE-Sepharose purified fractions containing EF-G,, activity were 
pooled and concentrated approximately g-fold against solid polyeth- 
ylene glycol to a volume of less than 24 ml. 
Sephaclyl S-200-The concentrated sample (16 ml, 160 mg of 
protein) was applied to an 800.ml Sephacryl S-200 column (4.5 X 51 
cm) equilibrated in buffer A. The column was developed with the 
same buffer at a flow rate of 1.5 ml/min, and 7.5 ml fractions were 
collected in siliconized tubes. The fractions containing EF-G,, activ- 
ity were pooled, concentrated to a final volume of approximately lo- 
15 ml against solid polyethylene glycol, and dialyzed for 5 h against 
two changes of buffer A. The sample was fast frozen in a dry ice/ 
isopropyl alcohol bath and stored at -70 “C. 
TS&el DEAE-SPW-Prior to application onto HPLC columns, 
all samples were filtered through a Nalgene 0.45-pm syringe filter. 
The dialyzed samnle (16 ml, 38 ma) was applied at a flow rate of 1 
ml/min to the TSi(ge1 DEAE-5PW column equilibrated in buffer A. 
The column was developed with a three-step programed gradient at 
a constant flow rate of 3 ml/min, and 5-ml fractions were collected 
in siliconized tubes. The first part of the gradient extended from 0.01 
to 0.12 M KC1 in buffer A in 20 min. This sten was followed bv a 
shallow rise for 160 min from 0.12 to 0.3 M KCl’in buffer A. Finally, 
the gradient ended with a 20 min rise to 0.4 M KC1 in buffer A. The 
material in the active fractions was pooled and concentrated against 
solid polyethylene glycol to a volume of approximately 10 ml and 
dialyzed against two changes of a 20-fold excess of buffer A for a total 
of 5 h. The sample was fast frozen in a dry ice/isopropyl alcohol bath 
and stored at -70 “C. 
Progel-TSK Heparim5P W-The TSKgel DEAE-5PW purified 
sample (10 ml, 4 mg) was applied at a flow rate of 1 ml/min to a 
Progel-TSK Heparin-5PW column equilibrated with buffer A. The 
column was washed with buffer A until the absorbance at 280 nm 
returned to base line. The column was then developed with a pro- 
gramed three-part gradient run at a constant flow rate of 0.25 ml/ 
min. In the first step, a linear gradient from 0.01 to 0.053 M KC1 in 
buffer A was run for 50 min. This step was followed by a wash with 
buffer A containing 0.053 M KC1 until the A2s0 returned to base line. 
Finally, a linear gradient from 0.053 to 0.15 M KC1 in buffer A was 
run for 140 min. Fractions (0.5 ml) were collected in Eppendorf tubes 
and active fractions were pooled and dialyzed against two changes of 
a 20-fold excess of buffer A for a total of 5 h. The sample was fast 
frozen in a dry ice/isopropyl alcohol bath and stored at -70 “C. 
TKSgel SP-5PW-In the final step, the Proeel-TSK Henarin- 
5PW sample (10 ml, 0.2 mg) was applied at a flow rate of 1 ml/min 
to a TSKgel SP-5PW column equilibrated with buffer A. The column 
was developed with a three-part gradient run at a flow rate of 0.25 
ml/min. In the first part, the column was washed for 20 min with 
buffer A containing 0.03 M KCl. Second, a linear gradient was run 
for 160 min from 0.03 to 0.15 M KC1 in buffer A. Finally, the salt 
concentration was raised from 0.15 to 0.2 M KC1 in buffer A over a 
40-min period. Fractions (0.5 ml) were collected in Eppendorf tubes 
and active fractions were fast frozen in a dry ice/isopropyl alcohol 
bath and stored at -70 “C until use. 
Assays 
EF-G,, was detected by its ability to replace E. coli EF-G in 
poly(U)-directed polymerization of phenylalanine on E. coli ribo- 
somes. Assay mixtures (0.1 ml) contained 50 mM Tris-HCl, pH 7.8, 
60 mM KCl, 7.5 mM MgC12, 0.1 mM spermine, 1 mM dithiothreitol, 
2.5 mM phosphoenolpyruvate, 0.17 units of nvruvate kinase. 0.5 mM 
GTP, 12.5 rgpoly(U),-35 pmol of [i4C]Phe-tgNA, 21.5 rg of partially 
purified E. coli EF-Tu/Ts, 0.48 A 2M of E. coli ribosomes, and the 
indicated amounts of EF-G,,. All dilutions of EF-G,, were done with 
buffer A containing 1 mg/ml bovine serum albumin. Incubation was 
carried out for 15 min at 37 “C, and the reaction was terminated by 
the addition of 5% trichloroacetic acid. Incorporation of [“Clphen- 
ylalanine into polvpeptide was determined as described (10). One unit 
is defined as the incorporation of 1 pmol of [i4C]phenylalanine into 
polypeptide. Blanks (approximately 0.5 pmol) representing the 
amount of label retained on the filter in the absence of EF-G,, have 
been subtracted from each value. Polymerization assays on mitochon- 
drial ribosomes were similar to those described above except that the 
concentration of KC1 was reduced to 50 mM and the MgClz concen- 
tration was increased to 8 mM. 
To determine the ability of GDP to protect EF-G,, from heat 
Protein concentrations after each chromatography step were de- 
termined by the procedure of Lowry et al. (14) or by the method of 
Sedmak and Grossberg (15) with modifications by Beardon et al. (16) 
using bovine serum albumin as a standard. 
RESULTS AND DISCUSSION 
Identification of the Bovine Liver Mitochondrial Tramlo- 
case-Crude extracts from mitochondria can replace E. coli 
EF-Tu/Ts and EF-G in poly(U)-directed polymerization 
when tested on E. coli ribosomes. This observation suggests 
the presence of comparable elongation factors in mammalian 
mitochondrial preparations. The EF-Gmt activity in these 
crude extracts remains quite stable when stored at -70 “C. 
However, due to the lability of EF-Tu/Ts,, (3), samples were 
generally processed within 1 week after preparation. The total 
initial activity of EF-G,, varied with different livers, and the 
most active preparations were often obtained from livers of 
black male Angus cattle. In order to obtain extracts having 
maximal activity, the liver was always placed on ice within 30 
min after the animal was slaughtered. 
Purification of the Bovine Liver EF-G,,-The purification 
scheme of EF-G,, consisted of both conventional gravity and 
high pressure liquid chromatography. In the first step of the 
isolation procedure, the crude mitochondrial extract (3) was 
applied to a gravity DEAE-Sepharose column. EF-G,, eluted 
immediately following EF-Tu/Ts,~ at 220 mM KC1 with about 
71% recovery of activity and a 27-fold increase in specific 
activity (Table I). This step separated EF-G,t from EF-Tu/ 
Tsmt (data not shown). The sample at this stage is quite stable 
and can be stored for several weeks at -70 “C. EF-G,, was 
further purified on a gel filtration column (Sephacryl S-200). 
This step resulted in an extremely high recovery of EF-G,, 
activity with a 4-fold increase in specific activity (Table I). 
The native molecular weight of EF-G,, was determined to be 
80,000 from a 50-ml S-200 column using yeast alcohol dehy- 
drogenase, bovine serum albumin, and hen ovalbumin as 
standard molecular weight markers. The molecular weight of 
EF-Gmt is comparable to those observed for other organellar 
translocases and for E. coli EF-G (4-8). 
The remainder of the purification scheme employed HPLC 
columns for effective purification of EF-Gmt. For the first 
HPLC purification step, the sample was applied to a TSKgel 
DEAE-5PW column. As indicated in Fig. 1, essentially all of 
the protein was retained by this resin. However, when the 
gradient was apphed, EF-G,, eluted toward the back of the 
main protein peak, and 75% of the enzyme activity could be 
recovered in fractions containing only 10% of the applied 
protein. This step allowed a B-fold increase in specific activity 
from the previous step (Table I). The sample was further 
purified after application onto a Progel-TSK heparin-sepha- 
rose-5PW column. As indicated in Fig. 2, the majority of the 
EF-G,, activity eluted with the front shoulder of the second 
protein peak. This step yielded 55% of the EF-G,t activity 
with lo-fold increase in specific activity from the previous 
purification step (Table I). EF-G,, activity at this stage 
appears to be labile upon prolonged storage at -70 “C due to 
low amounts of protein present (less than 0.5 mg). 
For the final purification of EF-G,, the sample was applied 
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TABLE I 
Purification of mitochondrial EF-G from bovine liver 
Based on 60 g of isolated mitochondria. 
Purification step Protein Total units Specific activity Total recovery Purification 
w Xl@ units/mg % -fold 
Mitochondrial extract (S30) 6,000 17 280 100 1 
DEAE-Sepharose 160 12 7,500 71 27 
Sephacryl S-200 38 12 32,500 70 114 
TSKgel DEAE-6PW 4 8.7 218,000 51 780 
Progel-TSK heparin-5PW 0.23 4.8 2,100,000 30 7,500 
TSKgel SP-5PW -a 0.4 - 2 























FIG. 1. TSKgel DEAE-5PW profile of EF-G,,. EF-G,, puri- 
fied by Sephacryl S-200 gel filtration column was subjected to chro- 
matography on TSKgel DEAE-5PW as described under “Experimen- 
tal Procedures.” Aliquots of each fraction were diluted lo-fold, and 
10-J samples were assayed for EF-G,, activity (0). Absorbance at 
280 nm (-) was monitored with an ISCO UA-5 absorbance monitor 
using a scale from 0 to 1. The column was developed with a non- 
linear salt gradient (- - -). 
to a TSKgel SP-5PW column. To preserve the maximum EF- 
G,t activity, this procedure was generally performed within 3 
days of the previous step. The final purification step resulted 
in an elution of a symmetrical protein peak containing about 
30-50% of input EF-G,, activity (Fig. 3). This step resulted 
in the removal of substantial amounts of contaminating pro- 
tein (Fig. 4). Sodium dodecyl sulfate-polyacrylamide gel elec- 
trophoresis analysis of each fraction from the TSKgel SP- 
5PW column containing EF-Gmt activity indicated that frac- 
tions from the front portion of the peak contained faint traces 
of contaminating proteins. Fractions corresponding to the 
center of the protein peak, which contained the highest EF- 
G,t activity, were purified essentially to homogeneity (Fig. 
4B). These fractions, representing about 10% of the input 
EF-G,, activity, were selected for the following characteriza- 
tion experiments. This sample is estimated to have a 2-fold 
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FIG. 2. Purification of EF-G,, on Progel-TSK Heparin- 
5PW column. The column was developed as described under “Ex- 
perimental Procedures.” Aliquots of each fraction were diluted 5-fold, 
and 5-4 samples were assayed for EF-G,, activity (0). Absorbance 
at 280 nm was monitored (-) using a scale from 0 to 0.5. A series 
of linear salt gradients (- - -) were used to develop the column. 
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FIG. 3. Elution profile of purified EF-G,, from TSKgel SP- 
5PW. A Progel-TSK purified sample was subjected to chromatogra- 
phy on TSKgel SP-5PW as described under “Experimental Proce- 
dures.” Aliquots of each fraction were diluted lo-fold, and 5-J sam- 
ples were assayed for EF-G,, activity (0). Absorbance at 280 nm was 
monitored (-) using a scale of 0 to 0.2. A three-part gradient 
(- - -) was used to develop the column. 
increase in specific activity from the previous step. The re- 
covery of EF-Gmt activity from the TSKgel SP-5PW column 
was dependent on the amount of protein loaded. Samples 
containing higher amounts of protein generally gave higher 
recoveries of activity. For this reason, we recommend that 
two to three samples purified up to the TSKgel DEAE-5PW 
stage be combined and processed together through the re- 
mainder of the purification scheme. The protein concentra- 
tion of the pure sample was difficult to determine precisely 
due to the very low amounts of protein present. The estimated 
amount of protein in the selected fractions containing the 
highly purified EF-G,, was about 10 Fg. Overall, this purifi- 






FIG. 4. Sodium dodecyl sulfate-polyacrylamide gel electro- 
Dhoresis analvsis of EF-G,,. A. samule nurified from Proeel-TSK 
ieparin-5PW i-O.5 pg). B,“mit&hon’drial EF-G purified-to near 
homogeneity (-0.2 pg). Proteins were analyzed on sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (10% acrylamide, 0.3% bis- 
acrylamide, and 3% stacking gel) according to the method by Laemmli 
(25) on a Bio-Rad Protean apparatus. The gel was developed with 
silver stain (26). Molecular weight markers: p-galactosidase (116,000), 
phosphorylase b (97,400), bovine serum albumin (SS,OOO), hen oval- 
bumin (45,000), and carbonic anhydrase (29,000). 
cation scheme results in approximately a 14,000-fold increase 
in the specific activity of EF-G,, with a total recovery of 
about 2% of the activity. 
The purified factor consists of a single polypeptide chain 
with a molecular weight of 80,000 (Fig. 4). This value corre- 
sponds to the molecular weight determined by gel filtration 
chromatography indicating that EF-G,, functions as a mon- 
omer. An estimate of the turn-over number indicated that 1 
pmol of EF-G,, promotes the incorporation of 300 pmol of 
phenylalanine in the poly(U)-directed polymerization assay. 
The approximate specific activity of the pure mammalian 
mitochondrial translocase is about 4 x 10’ units/mg protein. 
E. grucilis chloroplast and mitochondrial translocases have 
specific activities of about 1 x lo6 and 5 x lo“, respectively 
(4, 6). Pure cytoplasmic EF-2 from pig liver has a specific 
activity comparable to that of EF-G,, (9). 
Interchangeability of EF-G,, on Heterologous Ribosome-As 
indicated above, we routinely used E. coli ribosomes to assay 
the activity of EF-G,, in the poly(U)-directed polymerization 
assay. EF-G,, is equally active on heterologous E. coli ribo- 
somes as on its homologous ribosomes (data not shown). 
However, it has been shown (2) that mitochondrial ribosomes 
do not reciprocate this interchangeability, and E. coli EF-G 
shows no polymerization activity on mitochondrial ribosomes. 
This stringent recognition possibly suggests that mitochon- 
drial ribosomes have evolved a specific site on which only its 
homologous translocase can function. 
It has previously been reported that mammalian EF-G,, is 
not active on E. coli ribosomes (17). This observation was 
based on an effort to detect EF-G,, activity in poly(U)- 
directed polymerization assay using E. coli tRNA and [‘“Cl 
phenylalanine rather than precharged tRNA. We believe that 
the absence of activity in this system arose from a lack of 
tRNA charging rather than from a failure of EF-G,, to 
function on E. coli ribosomes. The above report also attempted 
to measure EF-G,, activity in crude mitochondrial extracts 
using an uncoupled GTPase assay in the presence of either 
mitochondrial or E. coli ribosomes. However, the amount of 
crude extract used probably contained too little EF-G,l to be 
detected in this assay. It is also conceivable that the mam- 
malian translocase may not possess an inherent uncoupled 
GTPase activity as does its prokaryotic counterpart. 
EF-G,r Protection from Heat Inactivation by Guanine NU- 
cleotides-Purified EF-G,, is quite stable at temperatures up 
to 37 “C, but its activity declines rapidly thereafter until 
complete inactivation is observed at 65 “C after 15 min of 
incubation (data not shown). We tested the ability of guanine 
nucleotides to protect EF-G,, from heat inactivation. As seen 
in Fig. 5, with 30 min of incubation at 44 “C, EF-G,, retained 
only 25% of its original activity. However, in the presence of 
GDP or GTP, EF-G,, retained 55 and 70% of its activity, 
respectively. All translocases which have been examined to 
date show an interaction with GTP (18, 19) and many are 
protected from heat inactivation by the presence of guanine 
nucleotides (20). This GTP protection effect has also been 
observed with the translocase from archaebacterium Hulobac- 
terium halobium (21). The protection observed is thought to 
be caused by the binding of GTP to the translocase, resulting 
in a conformational change of the protein. 
Effect of Fusidic Acid on EF-G,,,! Activity-Fusidic acid is a 
steroidal antibiotic which inhibits translocation by stabilizing 
the ribosome-translocase-GDP complex. All translocases 
tested to date display sensitivity to this antibiotic. However, 
as seen in Fig. 6, the mammalian mitochondrial translocase 
is completely resistant to fusidic acid when tested with its 
homologous ribosomes. When tested on E. coli ribosomes, EF- 
G,, loses 50% of its polymerization activity in the presence 
of 1 mM fusidic acid. Concentrations of the antibiotic required 
to inhibit 50% of a variety of translocases have been deter- 
mined (4). There is a variation of over 1000-fold in the 
antibiotic sensitivities by these factors. E. coli EF-G requires 
35 pM for inhibition, while the wheat germ cytoplasmic EF-2 
is inhibited by 9 pM fusidic acid. The organellar translocases 
EF-Gchl and EF-G,, from E. grucilis are inhibited by fusidic 
acid concentrations of 3 and 20 pM, respectively, when assayed 
on E. coli ribosomes, while the cytoplasmic factor EF-2 of this 
organism required 550 pM fusidic acid for inhibition when 
tested on wheat germ 80 S ribosomes. Yeast EF-G,, like the 
mammalian mitochondrial factor, requires up to 1 mM for 
50% inhibition when assayed on E. coli ribosomes. In general, 
fusidic acid sensitivity appears to be dependent primarily on 
the translocase and not the ribosome used (4). Bovine EF- 
G,,, however, appears to diverge from this pattern since it is 
resistant to fusidic acid on its homologous ribosomes, but is 
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FIG. 5. Effect of GDP or GTP on heat stability of EF-G,,. 
Aliquots containing EF-G,, were incubated at 44 “C in the absence 
(Cl) or presence (m) of GDP and in the absence (0) or presence (0) 
of GTP and assayed for activity as described under “Experimental 
Procedures.” 
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